🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
1.510
-0.100 (-6.21%)
Nov 19, 2026, 4:00 PM EST - Market closed

Polaryx Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Selling, General & Admin
3.171.561.541.01
Research & Development
4.416.272.812.77
Operating Expenses
7.587.824.353.78
Operating Income
-7.58-7.82-4.35-3.78
Other Non Operating Income (Expenses)
-1.17-1.16-260
Pretax Income
-8.75-8.99-30.36-3.78
Net Income
-8.75-8.99-30.36-3.78
Net Income to Common
-8.75-8.99-30.36-3.78
Net Income Growth
----
Shares Outstanding (Basic)
48453411
Shares Outstanding (Diluted)
48453411
Shares Change
10.44%32.81%219.94%-
EPS (Basic)
-0.18-0.20-0.89-0.35
EPS (Diluted)
-0.18-0.20-0.89-0.35
EPS Growth
----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
EBIT
-7.58-7.82-4.35-3.78
SEC Filings: 10-K · 10-Q